Evidence map›Paper›PMID 21781953›Full record

ArticleActa tropica2012

Prospects for malaria elimination in non-Amazonian regions of Latin America.

Sócrates Herrera, Martha Lucia Quiñones, Juan Pablo Quintero, Vladimir Corredor, Douglas O Fuller, Julio Cesar Mateus, Jose E Calzada, Juan B Gutierrez, Alejandro Llanos, Edison Soto and 7 more

Abstract read
In one paragraph

Article in Acta tropica, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Outbreak Investigation ofThe American journal of tropical medicine and hygiene · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Metabolomics in the fight against malaria.Memorias do Instituto Oswaldo Cruz · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 6 countries.

Sócrates HerreraCentro de Investigación Científica Caucaseco, Colombia. sherrera@inmuno.org
Martha Lucia Quiñones
Juan Pablo Quintero
Vladimir Corredor
Douglas O Fuller
Julio Cesar Mateus
Jose E Calzada
Juan B Gutierrez
Alejandro Llanos
Edison Soto
Clara Menendez
Yimin Wu
Pedro Alonso
Gabriel Carrasquilla
Mary Galinski
John C Beier
Myriam Arévalo-Herrera
Caucaseco Scientific Research Center · COUniversity of Miami · USEmory University · USFundación para la Educación y el Desarrollo Social · COFundación Santa Fe de Bogotá · COGlobal Fund to Fight AIDS, Tuberculosis and Malaria · CHInstituto Conmemorativo Gorgas de Estudios de la Salud · PAThe Ohio State University · USUniversidad del Valle · COUniversidad Peruana Cayetano Heredia · PEUniversitat de Barcelona · ESUniversitat Internacional de Catalunya · ES

Funding

Vector Biology Research and Integrated Vector Management For Malaria ControlU19AI089702 · NIAID · CAUCASECO SCIENTIFIC RESEARCH CENTER · PI HERRERA VALENCIA, SOCRATES · 2010 to 2016
$11.5M
NIAID NIH HHS U19 AI089702NIAID NIH HHS U19AI089702
6 · The paper itself

Abstract

Latin America contributes 1-1.2 million clinical malaria cases to the global malaria burden of about 300 million per year. In 21 malaria endemic countries, the population at risk in this region represents less than 10% of the total population exposed worldwide. Factors such as rapid deforestation, inadequate agricultural practices, climate change, political instability, and both increasing parasite drug resistance and vector resistance to insecticides contribute to malaria transmission. Recently, several malaria endemic countries have experienced a significant reduction in numbers of malaria cases. This is most likely due to actions taken by National Malaria Control Programs (NMCP) with the support from international funding agencies. We describe here the research strategies and activities to be undertaken by the Centro Latino Americano de Investigación en Malaria (CLAIM), a new research center established for the non-Amazonian region of Latin America by the National Institute of Allergy and Infectious Diseases (NIAID). Throughout a network of countries in the region, initially including Colombia, Guatemala, Panama, and Peru, CLAIM will address major gaps in our understanding of changing malaria epidemiology, vector biology and control, and clinical malaria mainly due to Plasmodium vivax. In close partnership with NMCPs, CLAIM seeks to conduct research on how and why malaria is decreasing in many countries of the region as a basis for developing and implementing new strategies that will accelerate malaria elimination.

Indexed as

Epidemiologic Research DesignAnimalsDelivery of Health CareDisease EradicationDrug ResistanceGenetic VariationHumansImidazolesInsect VectorsInternational CooperationLatin AmericaMalariaMalaria VaccinesNational Health ProgramsNiacinPlasmodiumimazapyrImidazolesMalaria VaccinesNiacin

Identifiers

PMID21781953
PMCPMC3224666
OpenAlexW2064299701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.